# Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-revacept-a-novel-lesion-directed-competitive-antagonist/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Katharina Mayer,Ralph Hein-Rothweiler,Stefanie Schüpke,Marion Janisch,Isabell Bernlochner,Gjin Ndrepepa,Dirk Sibbing,Tommaso Gori,Oliver Borst,Stefan Holdenrieder,Danny Kupka,Tobias Petzold,Christian Bradaric,Rainer Okrojek,David M. Leistner,Tobias Daniel Trippel,Thomas Münzel,Ulf Landmesser,Burkert Pieske,Andreas M. Zeiher,Meinrad Gawaz,Alexander Hapfelmeier,Karl‐Ludwig Laugwitz,Heribert Schunkert,Adnan Kastrati,Steffen Maßberg |
| Citations | 82 |
| DOI | 10.1001/jamacardio.2021.0475 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jamacardiology/articlepdf/2777812/jamacardiology_mayer_2021_oi_210010_1625699344.42446.pdf |
| OpenAlex ID | https://openalex.org/W3147389511 |
| PMID | 33787834 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Tobias Petzold](https://scholariq.org/researchers/tobias-petzold/)

## Paper journal

- [JAMA Cardiology](https://scholariq.org/journals/jama-cardiology/)

## Paper primary topic

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)

## Paper topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.